Cindy Eckert | |
|---|---|
 | |
| Born | New York, U.S. |
| Other names | Cindy Whitehead |
| Education | Marymount University (BBA) |
| Father | Fred J. Eckert |
Cindy Eckert is an American entrepreneur known for founding Sprout Pharmaceuticals. She subsequently founded The Pink Ceiling which invests in companies founded by, or delivering products for, women.[1] In November 2017, Eckert re-acquired Sprout Pharmaceuticals as part of a lawsuit settlement, and the rights to its drug Addyi, from Valeant after Valeant's stock collapsed due to insider trading and price jacking allegations.[2][3][4][5][6][excessive citations]
- ^ "This Entrepreneur Who Sold Her Company for $1 Billion Wants You to Throw Out the Unwritten Rules That Hold You Back". Entrepreneur.com. 14 July 2017. Retrieved 2017-08-05.
- ^ "Valeant Gives $1 Billion Female Libido Pill Back to Old Owners". Bloomberg. 6 November 2017. Retrieved 2018-01-23.
- ^ "Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit". BioSpace. Retrieved 2021-06-03.
- ^ "Ackman's Pershing Square, Valeant to appear in court to discuss an insider trading lawsuit settlement". CNBC. 2018-01-03. Retrieved 2021-06-03.
- ^ "Anger Behind the Scenes When Valeant Jacked Up Price by 2,700% for Lead Poisoning Drug". BioSpace. Retrieved 2021-06-03.
- ^ Morgenson, Gretchen (2016-07-29). "How Valeant Cashed In Twice on Higher Drug Prices". The New York Times. ISSN 0362-4331. Retrieved 2021-06-03.